US fines Glaxo Record $3bn for mis-Promoting Drugs
#1
GlaxoSmithKline paid for American psychiatrists to enjoy luxury weekends in Hawaii as it illegally sought to persuade them to prescribe an anti-depressant drug for children, US authorities alleged, as they handed the UK drugs company fines totalling a record $3bn (£1.9bn).

Quote:Since so many people around just pop whatever the doctors say this might prove interesting for those who don't read the labels for side effect or in this case outright mis-promoting two popular drugs...........Leonard

The historic penalty came as Britain's biggest drugmaker admitted to mis-promoting two medicines, Paxil and Wellbutrin, in the US between 1998 and 2003. The settlement also saw Glaxo admit that it failed properly to report all the necessary safety data to US regulators concerning Avandia, a diabetes drug, between 2001 and 2007.

The settlement ends a seven-year investigation into Glaxo's mis-promotion of medicines in the US, which is the company's largest research centre after Britain and home to almost a fifth of its 100,000 employees. Glaxo warned shareholders last November that it had put aside more than £2bn to pay for the settlement.

"We are determined to stop practices that jeopardise patients' health, harm taxpayers and violate public law," said James Cole, US deputy attorney general.

Glaxo admitted promoting Paxil, an anti-depressant, to patients under 18 even though it did not have permission from the Food and Drug Administration (FDA) to do so.

In 2000 and 2001, Glaxo's sales staff regularly held forums to discuss Paxil in destinations including Hawaii and Puerto Rico, where the psychiatrists attending were treated to golf, deep-sea fishing and balloon rides, according to the Department of Justice.

From............ http://www.telegraph.co.uk/finance/newsb...drugs.html
Reply
#2
It's not an eye for an eye. There were deaths. And, they will get to write this settlement off, and receive a special tax break to help them through their hour of difficulty.
Reply


Forum Jump:


Users browsing this thread: 1 Guest(s)